General Discussion
Related: Editorials & Other Articles, Issue Forums, Alliance Forums, Region ForumsTo battle high costs-Gov Newsom proposes California sell its own brand of generic prescription drugs
SACRAMENTO California would become the first state to sell its own brand of generic prescription drugs in an effort to drive down rising healthcare costs under a proposal Gov. Gavin Newsom is expected to unveil in his new state budget Friday.
A broad overview of the ambitious but still conceptual plan provided by Newsoms office says the state could contract with one or more generic drugmakers to manufacture certain prescriptions under the states own label. Those drugs would be available to all Californians for purchase, presumably at a lower cost. The governors office said the proposal would increase competition in the generic drug market, which in turn would lower prices for everyone.
Whether drugmakers would follow Californias lead as Newsoms administration has suggested is far from certain. And other key details, including what prescriptions would be manufactured, were not provided.
A trip to the doctors office, pharmacy or hospital shouldnt cost a months pay, Newsom said in a statement. The cost of healthcare is just too damn high, and California is fighting back.
MORE:
https://www.latimes.com/california/story/2020-01-09/california-generic-prescription-drugs-program-governor-gavin-newsom
Link to tweet
Sherman A1
(38,958 posts)Happy to see that some folks are looking around for different ideas on this vital topic.
mwooldri
(10,303 posts)And one that could make California money. Find a manufacturer who is willing to cooperate, and target those drugs where the generic cost is super high compared to the cost of making it. One that comes to mind is insulin. I'm sure private companies will scream "not fair!" but since big pharma has been price gouging Americans for far too long, time to hit them in the pocket book.
Other way is to write some specific anti price gouging laws targeted at big pharma and enforce them. If drug X costs $1 to make (including R&D costs), the company shouldn't need to sell it at a price north of $500 to make a decent profit. That kind of markup is simply obscene. So either control the prices legislatively or by using the free market by introducing a new competitor to the market.
Massacure
(7,523 posts)Yeah, diabetics get gouged on it. But being a hormone, it is considered a biological compound rather than a chemical one and so it has a lot of regulatory quirks around it. In March, new FDA regulations take effect that makes it easier to approval to sell bio-similar drugs. In fact, Eli Lily and Novo Nordisk are preparing for this; they both just cut their list prices by about 50%.
Evolve Dammit
(16,736 posts)mike_c
(36,281 posts)...that were developed at public expense or whose patents have expired. It would force pharma companies to compete with low priced alternatives. As I understand it, drug companies do little real R&D, relying upon universities with NIH and similar grants to do most actual drug research. A low priced alternative manufacturer would drive down big pharma prices faster than just about anything else. Make 'em compete with non-profit manufacturers.
Control-Z
(15,682 posts)I'll be looking forward to see how this goes.